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Abstract The Bcl-2-sensitive release of proteins such as 
cytochrome c from the mitochondrial intermembrane space into 
the cytosol is a critical early event in apoptosis. The 
mitochondrial permeability transition is also an important event 
in many forms of apoptotic cell death. To determine whether the 
permeability transition led to the release of apoptogenic proteins 
from mitochondria we induced the permeability transition in 
isolated rat liver mitochondria and characterised the proteins 
which were released. The permeability transition led to a 
generalised, non-specific release of proteins, including cyto-
chrome c, from the mitochondrial intermembrane space which 
was prevented by an inhibitor of the permeability transition. To 
determine the mechanism of this protein release we measured 
both mitochondrial matrix swelling and protein release during the 
permeability transition in media of different osmolarities. 
Protein release correlated with mitochondrial matrix swelling, 
therefore the permeability transition causes release of proteins 
from the intermembrane space by rupturing the mitochondrial 
outer membrane. Supporting an apoptotic role for the proteins 
released by this mechanism, supernatants from mitochondria 
undergoing the permeability transition caused apoptotic changes 
in isolated nuclei. These data support the proposal that the 
mitochondrial permeability transition can induce apoptosis by 
releasing apoptogenic proteins into the cytoplasm [Skulachev, 
V.P., FEBS Lett. 397 (1996) 7-10]. 
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1. Introduction 
Apoptotic death occurs when a cell activates an intrinsic 
death programme during development or following cell injury 
[1,2]. Mitochondria play a critical early role in this pathway of 
cell death by releasing signalling proteins from their inter-
membrane space into the cytoplasm [3-5], where they activate 
cysteine proteases leading to cell death [6,7]. Apoptogenic 
proteins released by mitochondria include cytochrome c (cyt 
c) [3,5,8] and a 50 k D a protease [4,9]. Protein release from 
the intermembrane space is blocked by the antiapoptotic pro-
tein Bcl-2 [3,5,9,10], therefore the Bcl-2-sensitive release of 
""Corresponding author. Fax: (64) (3) 479-7866. 
E-mail: murphy@sanger.otago.ac.nz 
Abbreviations: CsA, cyclosporin A; cyt c, cytochrome c; FCCP, 
carbonyl cyanide p-trifluoromethoxyphenylhydrazone; A\|/, mitochon-
drial membrane potential; PT, permeability transition; TPMP, 
methyltriphenylphosphonium cation 
proteins from the mitochondrial intermembrane space may be 
a critical early signalling step in apoptotic cell death [4,10,11]. 
The mechanism of mitochondrial intermembrane protein 
release during apoptosis is uncertain; one appealing possibil-
ity is that the mitochondrial permeability transition (PT) is 
involved [4,11]. The PT arises due to the formation of a pro-
tein pore in the mitochondrial inner membrane which depol-
arises mitochondria and renders them permeable to low mo-
lecular weight solutes [12]. A decrease in mitochondrial 
membrane potential (Ai|/) due to the PT is an early event in 
several types of apoptosis [12-15] and bongkrekic acid, an 
inhibitor of the PT, prevents both this A\|/ decrease and the 
subsequent apoptosis [16]. The antiapoptotic protein Bcl-2 
localises to the mitochondrial outer membrane [10] and over-
expression of this protein prevents the PT [4]. Mitochondria 
undergoing the PT in vitro release proteins that cause apop-
totic changes in isolated nuclei [17]. However, the mechanism 
by which the PT leads to release of apoptogenic proteins is 
uncertain. Furthermore, it is unclear if the PT is required for 
the release of cyt c from mitochondria as this release occurs in 
apoptotic cells without any apparent changes in mitochondrial 
A\|/ [3,5]. 
To clarify the relationship between the PT and the release 
of apoptogenic proteins from the mitochondrial intermem-
brane space we induced the PT in isolated rat liver mitochon-
dria and characterised the protein release. We then deter-
mined whether these proteins could induce apoptotic 
changes in isolated nuclei. 
2. Materials and methods 
2.1. Mitochondrial preparation and incubation 
Liver mitochondria were prepared from fed, female Wistar rats 
(150-200 g) by homogenisation and differential centrifugation in 
ice-cold medium containing 250 mM sucrose, 5 mM Tris-HCl and 
1 mM EGTA at pH 7.4 [18]. The final wash was in medium without 
EGTA and the mitochondria were resuspended at about 50 mg pro-
tein/ml as determined by the biuret method using BSA as a standard 
[19]. 
Mitochondria (10 mg protein/ml) were incubated at 37°C with 
shaking under 95% 02/5% CO2 in 2 ml medium containing 110 
mM KC1, 10 mM HEPES-KOH (pH 7.2), 65 nmol CaCl2/mg protein, 
20 mM succinate and 13 uM rotenone. For some incubations 500 nM 
cyclosporin A (CsA) was also present. After 1 min the PT was in-
duced by adding 15 mM K2HPO4 and 2 min later the mitochondria 
were pelleted by centrifugation (13000Xg for 30 s). The pellets were 
retained for analysis of proteins remaining in the mitochondria and 
the supernatants were concentrated ~ 4-fold using Centricon-3 cen-
trifugal microconcentrators (Amicon, USA), which retain molecules 
> 3 kDa. 
2.2. Characterisation of mitochondrial proteins released during the 
permeability transition 
The release of cyt c into the post-mitochondrial supernatant was 
confirmed by scanning absorption spectroscopy, after addition of di-
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thionite to reduce cyt c, and quantitated using 6550=27.7 m M - 1 cm - 1 . 
To quantitate cyt c release as a proportion of the total amount 
present, cyt c was extracted from the mitochondrial pellet by addition 
of butanol to 20% (v/v), emulsified by shaking and incubated at 0°C 
for 10 min [20]. The emulsion was then mixed 4:1 with saturated 
ammonium sulphate, shaken and incubated at room temperature for 
10 min. The two phases were separated by centrifugation (lOOOOXg 
for 1 min) and the lower, aqueous phase removed and its cyt c content 
determined as described above. 
Adenylate kinase was assayed [21] in buffer containing 5 mM 
MgS04 , 0.1% Triton X-100, 10 mM glucose, 1 mM ADP, 1 mM 
NADP+, 10 U glucose 6-phosphate dehydrogenase, 10 U hexokinase 
and 50 mM Tris-HCl, pH 7.5, at 30°C. The change in absorbance at 
340 nm (e = 6.22xl03 M _ 1 cm - 1) was recorded and the background 
rate, measured in the presence of the specific adenylate kinase inhib-
itor diadenosine pentaphosphate (100 uM), was subtracted from the 
initial rate. Citrate synthase was assayed in buffer containing 0.1% 
Triton X-100, 0.4 mM oxaloacetic acid, 0.1 mM 5,5'-dithiobis(2-nitro-
benzoic acid), 10 uM acetyl CoA, 100 mM Tris-HCl (pH 8), at 30°C 
and the increase in absorbance at 412 nm (e= 13.6X103 M _ 1 cm - 1) 
was recorded [22]. 
Proteins released by mitochondria were concentrated ~ 8-fold using 
Centricon-3 centrifugal microconcentrators, separated by discontinu-
ous polyacrylamide gel electrophoresis (17.5% acrylamide separating 
gel) using a BioRad Mini Protean system and visualised by Coomassie 
blue staining. To measure swelling, mitochondria (2 mg protein/ml) 
were incubated in a 3 ml stirred cuvette and the change in absorption 
at 540 nm recorded continuously using an Aminco DW2000 spectro-
photometer. Mitochondrial membrane potential was measured by 
incubating mitochondria with 1 uM (50 nCi/ml) [3H]methyltri-
phenylphosphonium (TPMP). The uptake of TPMP was determined 
by pelleting mitochondria by centrifugation followed by quantitation 
of the [3H]TPMP in the pellet and supernatant by scintillation count-
ing. The membrane potential was calculated from the Nernst equa-
tion, assuming a mitochondrial volume of 0.5 ul/mg protein and that 
60% of the intramitochondrial TPMP was membrane bound [23]. The 
protein released by mitochondria was quantitated using the bicincho-
ninic acid assay, with BSA as the standard [24]. 
2.3. Rat liver nuclei preparation and in vitro apoptosis assay 
Rat liver nuclei were prepared by a modification of a published 
method [25]. A female Wistar rat (150-200 g) was anaesthetised using 
pentobarbital and its liver was perfused briefly with ice-cold PBS, 
removed and then homogenised in ice-cold buffer A, containing 250 
mM sucrose, 1 mM dithiothreitol, 80 mM KC1, 15 mM NaCl, 5 mM 
EDTA, 0.5 mM spermidine, 0.2 mM spermine, 1 uM phenylmethyl-
sulphonyl fluoride and 15 mM PIPES (NaOH), pH 7.4. The homo-
genate was filtered through four layers of cheesecloth and added to 
1 vol. buffer B, containing 2.3 M sucrose, 1 mM dithiothreitol, 80 mM 
KC1, 15 mM NaCl, 5 mM EDTA, 0.5 mM spermidine, 0.2 mM 
spermine, 1 |iM phenylmethylsulphonyl fluoride and 15 mM PIPES 
(NaOH), pH 7.4. This was loaded onto a 5 ml cushion of buffer B and 
the nuclei were pelleted by centrifugation (22000Xg at 4°C for 1.5 h). 
The nuclear pellet was then resuspended at ~8.5X10 7 nuclei/ml in 
buffer A and aliquots were stored at —80°C. 
For the in vitro apoptosis assays 50 ul concentrated supernatant 
from a mitochondrial incubation was added to 3 ul 20 mM dATP, 3 ul 
20 mM MgCl2 and 6 ul nuclei ( ~ 5 X10
5 nuclei) and incubated for 2 h 
at 37°C [8], Apoptotic changes in the nuclei were visualised by mixing 
4 ul nuclear incubation with 1.5 ul Hoechst 33342 (10 uM in formalin) 
on a glass slide and then observed under UV illumination using a 
fluorescence microscope. DNA was extracted from the remaining 
nuclei with 500 ul buffer containing 100 mM Tris-HCl (pH 8.5), 
5 mM EDTA, 0.2 mM NaCl, 0.2% w/v SDS, and 0.2 mg/ml protein-
ase K and incubated at 37°C overnight. NaCl (final concentration 
1.5 M) was then added and the protein was pelleted by centrifugation 
(16000Xg for 15 min). The supernatant was mixed with 1 vol. Tris-
equilibrated phenol (pH 8)/chloroform (1:1), the aqueous layer re-
moved, mixed with 1 vol. isopropanol and stored at —20°C for 20 
min. The DNA was then pelleted by centrifugation (16000Xg for 15 
min at 4°C), washed with ice-cold 70% ethanol, resuspended in 40 ul 
H 2 0 containing 200 ug/ml RNase A, and incubated for 1 h at 37°C. 
The DNA was separated by electrophoresis on a 2% agarose gel run 
at 50 V for 2 h, and the DNA was visualised by ethidium bromide 
fluorescence under UV illumination. 
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Fig. 1. Release of proteins from the mitochondrial intermembrane 
space during the permeability transition. Mitochondria were incu-
bated with calcium as described in Section 2.1 and the PT was in-
duced by addition of phosphate. These experiments were repeated 
in the presence of CsA, or with FCCP added instead of phosphate. 
A: Analysis of the release of cyt c (black bars), adenylate kinase 
(white bars), and citrate synthase (shaded bars) from mitochondria. 
The proportions of the proteins released and remaining in the mito-
chondria are given as a percentage of the total amounts in the mito-
chondria. Data are the mean±S.E.M. of experiments on at least 
three separate mitochondrial preparations. B: Equal volumes of the 
concentrated supernatants from the mitochondrial incubations were 
separated by SDS-PAGE on a 17.5% acrylamide gel as described in 
Section 2.2. Purified horse heart cyt c (15 ug) was loaded where in-
dicated. 
3. Results 
3.1. Induction of the permeability transition releases proteins 
from the mitochondrial intermembrane space 
To determine whether the PT released proteins from the 
mitochondrial intermembrane space, mitochondria were incu-
bated with calcium as described in Section 2.1 and the PT was 
induced by addition of phosphate. These conditions are effec-
tive inducers of the PT [12] and this was confirmed under our 
conditions by parallel measurement of the mitochondrial Ay 
(data not shown). These A\|f measurements also confirmed 
that CsA prevented the P T following phosphate addition. 
The supernatants from these mitochondrial incubations were 
concentrated ~ 4-fold and proteins released from the mito-
chondria during the PT were characterised and quanti tated 
(Fig. 1). To determine whether cyt c was released from mito-
chondria during the PT a scanning absorption spectrum of the 
concentrated supernatant was obtained (data not shown). 
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This showed the characteristic absorption spectrum of cyt c 
and this cyt c release was blocked by CsA, which prevents the 
PT. The amount of cyt c lost from the mitochondria into the 
cytoplasm was about 30% of the total present (Fig. 1A). To 
determine whether this protein release during the PT was se-
lective for cyt c, or was general for all intermembrane space 
proteins, the concentrated supernatant was assayed for aden-
ylate kinase, a mitochondrial intermembrane space enzyme 
(Fig. 1A). The PT led to the loss of about 30% of adenylate 
kinase from the intermembrane space to the supernatant, 
about the same proportion lost as for cyt c (Fig. 1A). This 
loss of adenylate kinase was prevented by CsA, as was the 
case for cyt c (Fig. 1A). The mitochondrial matrix enzyme 
citrate synthase was not released from the mitochondria dur-
ing the PT (Fig. 1A), showing that the protein release was 
confined to intermembrane space proteins and was not due 
to a generalised breakdown of mitochondrial membranes. Ad-
dition of the mitochondrial uncoupler FCCP did not result in 
the release of intermembrane space proteins (Fig. 1A). To 
characterise further the proteins released from the mitochon-
dria during the PT, equal volumes of the concentrated super-
natants from the mitochondrial incubations were analysed by 
SDS-PAGE (Fig. IB). In control incubations, where mito-
chondria were incubated with calcium, the proteins in the 
supernatant were due to contamination of the mitochondrial 
preparation (Fig. IB). When the PT was induced by addition 
of phosphate there was a substantial increase in the amount of 
protein released from the mitochondria and all the proteins 
visible in the control sample were present in increased 
amounts (Fig. IB). By comparison with purified cyt c it is 
clear from the protein gel that cyt c is one of the proteins 
released from mitochondria during the PT (Fig. IB), corrob-
orating the evidence for cyt c release shown in Fig. 1A. This 
protein release was blocked by CsA (Fig. IB). Protein assays 
of the supernatant from mitochondria undergoing the PT 
contained about 60 |j,g more protein per mg mitochondrial 
protein added than was found in control incubations or 
when the PT was blocked by CsA. Addition of the uncoupler 
FCCP to the mitochondrial suspension did not release mito-
chondrial proteins into the supernatant (Fig. IB). 
Time (min) 
Fig. 2. Mitochondrial swelling during the permeability transition. 
Mitochondria were incubated in the presence of calcium as de-
scribed in Section 2.2 and the absorbance at 540 nm was measured 
continuously. The PT was induced at time zero by addition of phos-
phate. In trace a the medium was 195 mM mannitol, 25 mM su-
crose and 10 mM HEPES-KOH (pH 7.2). In traces b, d and e the 
medium was 110 mM KC1 and 10 mM HEPES-KOH (pH 7.2), as 
for Fig. 1. In trace c the KC1 concentration was increased to 400 
mM. For trace d, FCCP was added at time zero in place of phos-
phate, and for trace e, CsA was present. All traces are typical ex-
periments repeated on at least three separate mitochondrial prepara-
tions. 
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Fig. 3. Apoptogenic effects on isolated nuclei of proteins released 
from mitochondria. Concentrated supernatants were prepared as de-
scribed in Section 2.1 from mitochondrial incubations in the pres-
ence of calcium alone (control), or in which the PT was induced by 
phosphate, blocked by CsA or in which FCCP was added instead 
of phosphate. These supernatants were incubated with isolated nu-
clei which were then assayed for apoptotic changes as described in 
Section 2.3. A: DNA was extracted from nuclei incubated with the 
mitochondrial supernatants and separated on a 2% agarose gel. B 
and C: Nuclei were stained with Hoechst 33342 and viewed by fluo-
rescence microscopy. B: A typical non-apoptotic nucleus after incu-
bation with the supernatant from mitochondria incubated with CsA. 
C: A typical apoptotic nucleus after incubation with supernatant 
from mitochondria undergoing the PT. Nuclei incubated with the 
supernatant from control mitochondrial incubations were similar to 
the one shown in B (data not shown) while nuclei incubated with 
the supernatant from mitochondrial incubations treated with FCCP 
were similar to the one shown in C (data not shown). All panels 
show typical data repeated on at least three separate mitochondrial 
preparations. 
3.2. Protein release from the mitochondrial intermembrane 
space correlates with mitochondrial swelling 
The data described above show a generalised release of 
proteins from the mitochondrial intermembrane space during 
the PT. As the PT is associated with swelling of the mitochon-
drial matrix the most likely cause of this protein release is 
rupture of the outer membrane following swelling of the mi-
tochondrial matrix [11]. To determine whether this caused the 
protein release, we measured changes in the mitochondrial 
volume during the PT. This was done by measuring light 
scattering by mitochondria spectrophotometrically where a 
decrease in optical density at 540 nm indicates mitochondrial 
swelling [26]. Mitochondria suspended in a mannitol-sucrose 
buffer underwent large-amplitude swelling during the PT (Fig. 
2, trace a). Similar mitochondrial swelling occurred when the 
PT was induced in 110 mM KC1 buffer (Fig. 2, trace b) which 
was prevented by CsA (Fig. 2, trace e). When the KC1 con-
centration was increased to 400 mM, swelling during the PT 
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was greatly reduced (Fig. 2, trace c). However, the CsA-sen-
sitive PT still occurred under these conditions as was shown 
by parallel measurements of A\|/ (data not shown), therefore 
the decreased swelling is not due to inhibition of the PT. 
Addition of the mitochondrial uncoupler FCCP did not lead 
to mitochondrial swelling (Fig. 2, trace d). The amount of 
adenylate kinase released during the PT was measured to 
determine how the decreased swelling at higher KC1 concen-
trations affected protein release from the intermembrane space 
(data not shown). The higher KC1 concentration decreased the 
CsA-sensitive release of adenylate kinase by about 67%, there-
fore the protein release from the mitochondrial intermem-
brane space during the PT correlated with swelling. 
3.3. Proteins released from mitochondria during the 
permeability transition induce apoptotic changes in 
isolated nuclei 
To determine whether the proteins released from mitochon-
dria during the PT were apoptogenic, supernatants from mi-
tochondria undergoing the PT were concentrated and incu-
bated with isolated rat liver nuclei. Addition of proteins 
released from mitochondria during the PT led to chromatin 
condensation (Fig. 3C) and DNA fragmentation (Fig. 3A) in 
the isolated nuclei, suggesting that these proteins were apop-
togenic. In contrast, supernatants from mitochondrial incuba-
tions in which the PT was prevented by CsA did not cause 
apoptotic changes in the nuclei (Fig. 3A,B). Interestingly, 
supernatants from mitochondria incubated with the uncoupler 
FCCP also induced apoptotic changes in nuclei, even though 
FCCP did not cause mitochondrial swelling (Fig. 2B) or re-
lease of proteins from the mitochondrial intermembrane space 
(Fig. 1A,B). 
4. Discussion 
The aim of this study was to characterise the release of 
apoptogenic proteins from mitochondria during the PT. The 
data shown in Fig. 1 demonstrate that the PT leads to the 
generalised release of proteins from the mitochondrial inter-
membrane space, and not to the selective release of particular 
proteins. This is supported by our finding that the same pro-
portion (~30%) of two intermembrane proteins, adenylate 
kinase and cyt c, was released during the PT. Further quanti-
tative and qualitative measurements of the released proteins 
also showed that the PT in vitro led to generalised protein 
release. During this work another report was published show-
ing cyt c release from mitochondria in vitro during the PT [27] 
and our study confirms and extends this observation. 
This generalised release of intermembrane proteins prob-
ably occurs by rupture of the mitochondrial outer membrane, 
due to osmotic swelling of the mitochondrial matrix during 
the PT [11]. This was supported by our finding that the pro-
tein release correlated with mitochondrial swelling, with both 
protein release and mitochondrial swelling decreasing in me-
dium of high osmotic strength (Fig. 2). Together these find-
ings demonstrate that the PT in vitro releases proteins from 
the mitochondrial intermembrane space. However, it remains 
to be seen whether the PT in vivo also ruptures the mitochon-
drial outer membrane, causing the generalised release of in-
termembrane space proteins. In particular, it is now important 
to determine whether the release of cyt c from the mitochon-
dria within intact cells during apoptosis occurs as a conse-
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quence of the PT, or by some other mechanism [3,5,6]. In 
some studies cyt c release occurred without a decrease in Ay 
[3,5,6], suggesting that the PT was not involved. One possi-
bility is that a specific release pathway exists for some mito-
chondrial proteins which operates independently of the PT. 
However, it should be remembered that the PT is reversible 
[12]. Therefore the PT may cause an individual mitochondrion 
to swell, releasing apoptogenic proteins and then reverse the 
PT and regenerate its A\|/. Such a process would enable the PT 
to release cyt c in vivo without any measurable change in 
mitochondrial Av|/ and may explain the apparent discrepancy 
in the literature. 
The proteins released from the mitochondrial intermem-
brane space by the PT induced apoptotic changes in isolated 
nuclei. This is consistent with the large amount of data show-
ing that the release of intermembrane proteins leads to apop-
togenic changes in isolated nuclei. Therefore, the Bcl-2-sensi-
tive induction of the PT may be an important event in 
apoptotic signalling. Surprisingly, in our experiments the un-
coupler FCCP also released factors from mitochondria which 
led to apoptotic changes in isolated nuclei, even though FCCP 
did not cause significant swelling or protein release: we are 
investigating this finding further. In summary, we have shown 
that induction of the PT leads to the generalised release of 
mitochondrial intermembrane space proteins by rupturing the 
mitochondrial outer membrane. These proteins can induce 
apoptotic changes in isolated nuclei. 
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